EPROPA

EPROPA (European Program for ROutine testing of Patients with Advanced lung cancer)

EPROPA (European Program for ROutine testing of Patients with Advanced lung cancer) is the new ambitious and innovative initiative promotoed by WALCE at European level:

a support program for advanced non-small cell lung cancer (NSCLC) patients to offer equal access to molecular tests, drugs and clinical trials available in Europe.

• Are you a patient, and would you have more information about this program?

—> Check the project’s official website: epropa.eu, and the leaflet (PDF)

• Are you a doctor, and would you have more information about this program?

—> Check the project’s official website: epropa.eu, and the leaflet (PDF)

__________________________________________________________________________

- Following you can find the WEBEX link to access to the EPROPA project’s virtual Press Conference: https://unito.webex.com/unito/onstage/g.php?MTID=e408edb67d7f61e2ad4b19a39ae6285ff

- This on line event will be streamed on Wednesday 16th DEC 2020, at 11 am (CET).

__________________________________________________________________________

Comments are closed.